This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Tomohiro Watanabe: Innovator in Inflammation Treatment
Introduction
Tomohiro Watanabe is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of inflammation. His innovative approach has led to the development of a unique method that utilizes muramyl dipeptide (MDP) for therapeutic purposes.
Latest Patents
Watanabe holds a patent for the use of muramyl dipeptide (MDP) in treating inflammation. The patent outlines a method for treating or preventing inflammation in a subject by administering an effective amount of MDP. This invention represents a promising advancement in the management of inflammatory conditions.
Career Highlights
Watanabe is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to engage in groundbreaking research and contribute to the scientific community.
Collaborations
Throughout his career, Watanabe has collaborated with esteemed colleagues, including Warren Strober and Ivan J Fuss. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Tomohiro Watanabe's innovative work in the field of inflammation treatment exemplifies the importance of scientific research in improving health outcomes. His contributions continue to inspire advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile